ANN ARBOR, Mich., August 14, 2025–ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today provided a business update and reported financial results for the three and six months ended June 30, 2025.Read More
ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results
